ZK-304709

N/A

Report date: 2023/11/29 17:36:49

NME

Base Information

Drug NameZK-304709

Drug Alias NameZK-304709ZK-CDK

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPlatelet-derived growth factor receptor inhibitorsVascular endothelial growth factor receptor 3 antagonistsVascular endothelial growth factor receptor 1 antagonists +[7]

TargetsCyclin-dependent kinase 1Vascular endothelial growth factor receptor 1Vascular endothelial growth factor receptor 3 +[7]

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBayer AG

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBayer AG

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A